INTERPACE BIOSCIENCES, INC. (IDXG) › Gross ProfitINTERPACE BIOSCIENCES, INC. (IDXG) — Gross ProfitAnnual figures by fiscal year, from SEC filings.2010: $26.55M2011: $32.47M2012: $26.86M2013: $23.50M2014: $206.0K2015: $2.52M2016: $6.44M2017: $8.54M2018: $11.70M2019: $8.33M2020: $10.72M2021: $18.80M2022: $18.23M2023: $25.06M2024: $29.93M2025: $24.13M$24.13M2010Gross Profit (USD)2025Fiscal YearGross ProfitChange YoY2025$24.13M-19.4%2024$29.93M+19.4%2023$25.06M+37.4%2022$18.23M-3.0%2021$18.80M+75.3%2020$10.72M+28.7%2019$8.33M-28.8%2018$11.70M+37.0%2017$8.54M+32.5%2016$6.44M+155.5%2015$2.52M+1124.3%2014$206.0K-99.1%2013$23.50M-12.5%2012$26.86M-17.3%2011$32.47M+22.3%2010$26.55M—Other metrics: RevenueCost of RevenueOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share